Hannah has completed her second masters degree, with distinction, from Queens University Belfast in Northern Ireland. This comes after having completed a project identifying genes which can potentially help physicians identify drug resistance in kidney cancer patients before treatment, as well as investigating the efficacy of drug combinations in resistant and susceptible cell lines.